Synthesis and biological evaluation of novel triazoles and isoxazoles linked 2-phenyl benzothiazole as potential anticancer agents. 2012

Ravindra M Kumbhare, and Umesh B Kosurkar, and M Janaki Ramaiah, and Tulshiram L Dadmal, and S N C V L Pushpavalli, and Manika Pal-Bhadra
Fluoroorganic Division, Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500607, India. rakumbhare@yahoo.com

A new series of isoxazoles and triazoles linked 2-phenyl benzothiazole were synthesized and evaluated for their anticancer activity. These compounds have been tested for their cytotoxicity three cancer cell lines. Among the compounds tested, compound 5d showed good cytotoxicity against Colo-205 and A549 cells in comparison to standard control PMX 610(1). Further compound 5d has been tested for its apoptotic activity and its inhibitory activity against caspase and PARP proteins. Hence this compound has the potential that it can be selected for further biological studies.

UI MeSH Term Description Entries
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Ravindra M Kumbhare, and Umesh B Kosurkar, and M Janaki Ramaiah, and Tulshiram L Dadmal, and S N C V L Pushpavalli, and Manika Pal-Bhadra
March 2012, Molecules (Basel, Switzerland),
Ravindra M Kumbhare, and Umesh B Kosurkar, and M Janaki Ramaiah, and Tulshiram L Dadmal, and S N C V L Pushpavalli, and Manika Pal-Bhadra
September 2014, Bioorganic & medicinal chemistry letters,
Ravindra M Kumbhare, and Umesh B Kosurkar, and M Janaki Ramaiah, and Tulshiram L Dadmal, and S N C V L Pushpavalli, and Manika Pal-Bhadra
January 2024, Frontiers in chemistry,
Ravindra M Kumbhare, and Umesh B Kosurkar, and M Janaki Ramaiah, and Tulshiram L Dadmal, and S N C V L Pushpavalli, and Manika Pal-Bhadra
January 2012, American journal of biomedical sciences,
Ravindra M Kumbhare, and Umesh B Kosurkar, and M Janaki Ramaiah, and Tulshiram L Dadmal, and S N C V L Pushpavalli, and Manika Pal-Bhadra
February 2016, Molecules (Basel, Switzerland),
Ravindra M Kumbhare, and Umesh B Kosurkar, and M Janaki Ramaiah, and Tulshiram L Dadmal, and S N C V L Pushpavalli, and Manika Pal-Bhadra
January 2007, Arzneimittel-Forschung,
Ravindra M Kumbhare, and Umesh B Kosurkar, and M Janaki Ramaiah, and Tulshiram L Dadmal, and S N C V L Pushpavalli, and Manika Pal-Bhadra
January 2018, Anti-cancer agents in medicinal chemistry,
Ravindra M Kumbhare, and Umesh B Kosurkar, and M Janaki Ramaiah, and Tulshiram L Dadmal, and S N C V L Pushpavalli, and Manika Pal-Bhadra
March 2005, Journal of medicinal chemistry,
Ravindra M Kumbhare, and Umesh B Kosurkar, and M Janaki Ramaiah, and Tulshiram L Dadmal, and S N C V L Pushpavalli, and Manika Pal-Bhadra
June 2008, Organic & biomolecular chemistry,
Ravindra M Kumbhare, and Umesh B Kosurkar, and M Janaki Ramaiah, and Tulshiram L Dadmal, and S N C V L Pushpavalli, and Manika Pal-Bhadra
January 2006, Journal of medicinal chemistry,
Copied contents to your clipboard!